Market Overview

Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC

Related SNY
Catalyst Alert: Amgen/Regeneron Patent Case Appeal Could Be Decided By April
Why The Amgen/Regeneron Patent Saga Is Far From Over
Pfizer: 2 Risks Every Shareholder Should Be Aware Of (Seeking Alpha)
Related JNJ
The Fentanyl Abuse Epidemic
Execs Giving CES Keynote Speeches Could Create Volatility For Shareholders
Altria: Income And Growth Together In A Defensive Business (Seeking Alpha)

Sanofi (NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids^® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Posted-In: News M&A


Related Articles (JNJ + SNY)

View Comments and Join the Discussion!